ID

34356

Descripción

Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan; ODM derived from: https://clinicaltrials.gov/show/NCT01777061

Link

https://clinicaltrials.gov/show/NCT01777061

Palabras clave

Versiones (1)
  1. 16/1/19 16/1/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

16 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01777061

Inglés

Eligibility Prostate Cancer NCT01777061

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
positive for recurrent prostate cancer by psa criteria
Descripción

Prostate cancer recurrent Positive | Prostate-Specific Antigen criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0278838
UMLS CUI [1,2]
C1514241
UMLS CUI [2,1]
C0138741
UMLS CUI [2,2]
C0243161
recurrence definition:
Descripción

Recurrence Definition

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034897
UMLS CUI [1,2]
C1704788
status post-operative radical prostatectomy, recurrence is defined by a psa of greater than or equal to 0.2 ng/ml
Descripción

Radical prostatectomy Postoperative state | Recurrence Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0194810
UMLS CUI [1,2]
C0231287
UMLS CUI [2,1]
C0034897
UMLS CUI [2,2]
C0201544
patients who have failed external beam radiation, or status post-brachytherapy, have recurrence as defined as psa above 2.0 ng/ml the nadir psa after treatment
Descripción

External Beam Radiation Therapy failed | Status post Brachytherapy | Recurrence Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1517033
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0006098
UMLS CUI [3,1]
C0034897
UMLS CUI [3,2]
C0201544
subject is able to comprehend the study objectives and provide written informed consent before the initiation of any study-related procedures.
Descripción

Comprehension Study Protocol | Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
eastern cooperative oncology group (ecog) status of ≥ 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
any other concurrent malignancy
Descripción

Cancer Other

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707251
patients without remission of disease (no psa decrease)
Descripción

Disease remission Absent | Prostatic specific antigen decrease Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0544452
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0178414
UMLS CUI [2,2]
C0332197
patients without recurrence of disease (psa remains low)
Descripción

Recurrent disease Absent | PSA Level low

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0277556
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C4086720
UMLS CUI [2,2]
C0205251
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT01777061

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate cancer recurrent Positive | Prostate-Specific Antigen criteria
Item
positive for recurrent prostate cancer by psa criteria
boolean
C0278838 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0138741 (UMLS CUI [2,1])
C0243161 (UMLS CUI [2,2])
Recurrence Definition
Item
recurrence definition:
boolean
C0034897 (UMLS CUI [1,1])
C1704788 (UMLS CUI [1,2])
Radical prostatectomy Postoperative state | Recurrence Prostate specific antigen measurement
Item
status post-operative radical prostatectomy, recurrence is defined by a psa of greater than or equal to 0.2 ng/ml
boolean
C0194810 (UMLS CUI [1,1])
C0231287 (UMLS CUI [1,2])
C0034897 (UMLS CUI [2,1])
C0201544 (UMLS CUI [2,2])
External Beam Radiation Therapy failed | Status post Brachytherapy | Recurrence Prostate specific antigen measurement
Item
patients who have failed external beam radiation, or status post-brachytherapy, have recurrence as defined as psa above 2.0 ng/ml the nadir psa after treatment
boolean
C1517033 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0006098 (UMLS CUI [2,2])
C0034897 (UMLS CUI [3,1])
C0201544 (UMLS CUI [3,2])
Comprehension Study Protocol | Informed Consent
Item
subject is able to comprehend the study objectives and provide written informed consent before the initiation of any study-related procedures.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
ECOG performance status
Item
eastern cooperative oncology group (ecog) status of ≥ 2
boolean
C1520224 (UMLS CUI [1])
Cancer Other
Item
any other concurrent malignancy
boolean
C1707251 (UMLS CUI [1])
Disease remission Absent | Prostatic specific antigen decrease Absent
Item
patients without remission of disease (no psa decrease)
boolean
C0544452 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0178414 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Recurrent disease Absent | PSA Level low
Item
patients without recurrence of disease (psa remains low)
boolean
C0277556 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C4086720 (UMLS CUI [2,1])
C0205251 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial